EUCTR2007-004474-24-NL进行中（未招募）1 期
HD 16 for early stages: treatment optimization trial in the first-line treatment of early stage Hodgkin lymphoma; treatment stratification by means of FDG-PET. - HD 16
VU University Medical Center0 个研究点目标入组 1,150 人开始时间: 2010年7月2日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 1,150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1.Histologically proven primary diagnosis of Hodgkin lymphoma;
- •2. Stage: I and II without risk factor
- •3. Patient had no previous treatment for HL;
- •4. Age at entry: 18 - 75 years;
- •5. 6. Normal organ function (except HL-related);
- •6. Negative HIV test
- •7. In women: negative pregnancy test
- •8. Life expectancy > 3 months
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Incomplete diagnosis of the disease stage;
- •2. Prior or concurrent disease that prevents treatment according to protocol;
- •3. HL as composite lymphoma;
- •4. Prior chemotherapy or radiation;
- •5. Malignant disease within the last 5 years (exceptions: basalioma, carcinoma in
- •situ of the cervix uteri, completely resected melanoma TNMpT1);
- •6. Pregnancy, lactation;
- •7. WHO activity index > 2;
- •8. Long-term administration of corticosteroids (e.g. for chronic polyarthritis) or
- •antineoplastic drugs (e.g. methotrexate)
- •9. Non-compliance
研究者
相似试验
进行中（未招募）
1 期
A study to improve the treatment in the first-line treatment of advanced stage Hodgkin lymphomaTreatment optimization trial in the first-line treatment of advanced stage Hodgkin lymphomaMedDRA version: 20.0Level: HLGTClassification code 10025319Term: Lymphomas Hodgkin's diseaseSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2014-005130-55-DEniversity of Cologne1,500
进行中（未招募）
1 期
A study to improve the treatment in the first-line treatmend of advanced stage Hodgkin lymphomaEUCTR2014-005130-55-DKniversity of Cologne1,500
已完成
3 期
HD212024-518022-33-00University Of Cologne1,320
进行中（未招募）
1 期
A study to improve the treatment in the first-line treatmend of advanced stage Hodgkin lymphomaTreatment optimization trial in the first-line treatment of advanced stage Hodgkin lymphomaMedDRA version: 20.0Level: HLGTClassification code 10025319Term: Lymphomas Hodgkin's diseaseSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2014-005130-55-SEniversity of Cologne1,500
招募中
3 期
HD21 for advanced stages: Treatment optimization trial in the first-line treatment of advanced stage Hodgkin lymphoma; comparison of 4-6 cycles of escalated BEACOPP with 4-6 cycles of BrECADD; a randomized phase III trialHodgkin's disease10025319malignant lymphomaNL-OMON50640niversitly of Cologne100